Sensitivity of CLL sample to BRB was not found to correlate with clinical parameters (Binet disease stage) nor with molecular prognostic markers (mutational status of the IGHV, CD38 expression). Here, CD38 is linked to B-cell chronic lymphocytic leukemia.